Navigation Links
Paul Pospisil Joins Korn/Ferry as Senior Client Partner in Biotechnology and Life Sciences Practice
Date:1/6/2011

NEW YORK, Jan. 6, 2011 /PRNewswire/ -- Korn/Ferry International (NYSE: KFY), a premier global provider of talent management solutions, today announced that Paul Pospisil, Ph.D. has joined the Firm as a Senior Client Partner in the Biotechnology and Life Sciences Practice.  He will be based out of the Firm's New York office.

Mr. Pospisil joins Korn/Ferry after serving more than 15 years as an investor and operating executive in the biotechnology industry.  He brings to the Firm strong experience in drug discovery and development, finance, business development, technology assessment and evaluation, and business strategy.

Throughout his career, Mr. Pospisil has held senior-level positions at widely-regarded consulting and venture capital firms, as well as leading globally-focused biotechnology and bio-pharmaceutical organizations.

"Paul's unique credentials as both an investor and biotechnology executive, coupled with his vast knowledge of the issues and trends driving the industry, will be a great fit for our entrepreneurial life sciences clients," said Stephen Israel, Korn/Ferry's managing director, biotechnology and pharmaceuticals.

Mr. Pospisil joins the Firm from Aduro Capital LLC, an investment management company focused on the public healthcare sector and Aduro Partners LLC, an advisory firm focused on helping venture-backed and public life science companies assess, evaluate, partner opportunities and build businesses.  Previously, he was a partner in life science investments at Atlas Venture and earlier was with Millennium Pharmaceuticals, where his last position was director, strategy leadership.  Earlier, he was a new product manager at Altus Biologics, a spin-out of Vertex Pharmaceuticals.

Mr. Pospisil received a Ph.D. in Organic Chemistry from Harvard University and a Bachelor of Arts in Biochemistry from New York University.  He also attended Harvard Business School's Program for Management Development (PMD).

About Korn/Ferry International

Korn/Ferry International, with a presence throughout the Americas, Asia Pacific, Europe, the Middle East and Africa, is a premier global provider of talent management solutions. Based in Los Angeles, the firm delivers an array of solutions that help clients to attract, develop, retain and sustain their talent. Visit www.kornferry.com for more information on the Korn/Ferry International family of companies, and www.kornferryinstitute.com for thought leadership, intellectual property and research.


'/>"/>
SOURCE Korn/Ferry International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Jack Davis, Diagnostics Industry Executive, Joins the HistoRx Board of Directors
2. Dr. Russell L. Chapman Joins Aquatic Energy as the Chairman of its Science Advisory Board
3. Dr. Michael Hanley Joins Celtaxsys as CEO
4. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
5. Distinguished Scientist H. Mario Geysen Joins SRI International to Lead Combinatorial Sciences and Metabolic Diseases Research Programs
6. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
7. Todd Park, Chief Technology Officer of U.S. Department of Health and Human Services, Joins Opening Keynote Line-Up at 2010 mHealth Summit
8. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
9. Excerpta Medica Joins Adelphi Worldwide
10. Philadelphia Eagles Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line
11. Christopher Bowe Joins Scrip as US Healthcare Analyst
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... ... AMRI, a global contract research, development and manufacturing organization ... quality of life, will now be offering its impurity solutions as a stand-alone ... for all new drug products, including the finalization of ICH M7 earlier this ...
(Date:10/11/2017)... ... 11, 2017 , ... Personal eye wash is a basic first aid supply for any work ... which eye do you rinse first if a dangerous substance enters both eyes? It’s one ... with its unique dual eye piece. , “Whether its dirt and debris, or an ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
Breaking Biology Technology:
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
Breaking Biology News(10 mins):